Yale-New Haven Hospital

Name

Yale-New Haven Hospital

Legal name

Yale New Haven Hospital

Website

https://ynhh.org

Company type

Private

Founded year

1826

Operating status

Operating

Headcount range

10,001+ employees

Ownership category

akta.pro rank

Product category

Academic Medical Center / Tertiary Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Psychiatric and Substance Abuse Hospitals (62221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

akta.pro secondary industries

Community & Regional General Hospitals (HLAFAAAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Children’s Hospitals (Acute Care) (HLAFAAAI)

Keywords

• Academic medical center
• Hospital services
• Cancer care
• Pediatric healthcare
• Organ transplantation

Headquarters

HQ city

New Haven

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Healthcare Services Revenue: Yale New Haven Hospital generates revenue through comprehensive patient care services including inpatient hospitalizations, outpatient visits, emergency services, surgical procedures, diagnostic testing, and specialized treatments across more than 100 medical specialties. Revenue is derived from insurance reimbursements (Medicare, Medicaid, and commercial payers), patient payments, and charity care programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Yale-New Haven Hospital is a 1,541-bed nonprofit academic medical center providing inpatient, outpatient, emergency, surgical, and diagnostic services across more than 100 medical specialties. It operates four main campuses (York Street, Saint Raphael, Smilow Cancer Hospital, Yale New Haven Children's Hospital, and Yale New Haven Psychiatric Hospital) and serves as the primary teaching hospital of Yale School of Medicine, generating revenue through insurance reimbursements, patient payments, and charity care programs.

Product overview

Yale-New Haven Hospital operates as a multi-campus academic medical center system comprising four main facilities: York Street Campus (1,541 beds flagship hospital), Smilow Cancer Hospital, Yale New Haven Children's Hospital, and Yale New Haven Psychiatric Hospital. The hospital provides comprehensive healthcare services across more than 100 specialties including Heart & Vascular, Cancer/Oncology, Digestive Health, Neurology & Neurosurgery, Maternity, Psychiatry, Radiology, and Transplantation. The system also includes digital health services through MyChart patient portal, AI-enabled diagnostic tools through Tempus AI partnership (ECG analysis and digital pathology), and serves as the primary teaching hospital of Yale School of Medicine. Key clinical programs include the Adams Neurosciences Center (opening 2027) and various specialized surgical programs including robotic-assisted procedures.

Differentiator

Problem solved

Functional benefit

Products and services

• Yale New Haven Hospital (York Street Campus) Connecticut's largest hospital system flagship campus with 1,541 beds, providing comprehensive care across more than 100 specialties and serving as the primary teaching hospital of Yale School of Medicine.
• Smilow Cancer Hospital at Yale New Haven Connecticut's only NCI-designated comprehensive cancer center (via Yale Cancer Center affiliation), offering 13 specialized cancer programs with multidisciplinary teams, clinical trials, and genetic counseling.
• Yale New Haven Children's Hospital

Quantifiable outcome

• Smilow Cancer Hospital treats more cancer patients than any other hospital in Connecticut
• +5 more outcomes

Named customers3 records

Segments8 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• VahatiCor, Inc.coreStrategic or Co-development Partner · 17 June 2026VahatiCor, a medtech company developing interventional therapies for coronary microvascular dysfunction (CMD), enrolled the first U.S. patient in its SERRA-I early feasibility study of the A-FLUX Reducer System at Yale New Haven Hospital. The A-FLUX Reducer System is a self-expanding nitinol implant designed to address CMD by influencing blood flow through smaller heart vessels.
• Tempus AIcoreStrategic or Co-development Partner · 16 June 2026Tempus AI launched an open-source digital pathology IMS Consortium with Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center as founding members. The consortium aims to develop a standardized, open digital pathology platform by open-sourcing Tempus's existing system including slide viewer, case management, and AI modules. This initiative seeks to accelerate digital pathology adoption and improve clinical workflows through open innovation and shared standards.
• Memorial Sloan Kettering Cancer Center (MSK)coreStrategic or Co-development Partner · 16 June 2026Memorial Sloan Kettering Cancer Center joined Tempus AI's open-source digital pathology IMS Consortium as a founding member alongside Yale New Haven Hospital. The consortium aims to develop standardized, open digital pathology solutions and improve clinical workflows through shared standards and open innovation.
• TruvetacoreStrategic or Co-development Partner · 21 May 2026A peer-reviewed study led by Truveta in collaboration with Yale School of Medicine, Yale New Haven Hospital, and Duke University School of Medicine was published in JAMA Network Open. The study found major gaps in follow-up care for patients with heart failure, examining over 340,000 patients with newly diagnosed heart failure with reduced ejection fraction.
• Yale School of MedicinecoreStrategic or Co-development Partner · 21 May 2026Yale School of Medicine collaborated with Yale New Haven Hospital and Truveta on a major JAMA Network Open study examining heart failure patient outcomes. Yale School of Medicine faculty and researchers participate in clinical care, research, and education programs at the hospital.
• Duke University School of MedicineminorStrategic or Co-development Partner · 21 May 2026Duke University School of Medicine collaborated with Yale School of Medicine, Yale New Haven Hospital, and Truveta on a study examining follow-up care for heart failure patients, published in JAMA Network Open.
• Science CorpcoreStrategic or Co-development Partner · 15 April 2026Science Corp, a neurotechnology company co-founded by Max Hodak after departing Neuralink in 2021, successfully implanted its biohybrid cortical sensor in a human patient for the first time at Yale New Haven Hospital. This marks the first time a biohybrid neural interface has been placed in a person. The early feasibility study is overseen by neurosurgeon Dr. Dennis Spencer.
• MMI (Medical Microinstruments, Inc.)coreStrategic or Co-development Partner · 9 April 2026MMI announced the commercial launch in the U.S. of the world's first Robotic Suture purpose-built for its Symani Surgical System, developed in partnership with Kono Seisakusho Co., Ltd. (Crownjun). Dr. Siba Haykal at Yale New Haven Hospital performed the first clinical cases using the new suture.
• Yale School of MedicinecoreStrategic or Co-development Partner · 13 October 2025Ukrainian doctors began advanced pain management training at Yale School of Medicine and Yale New Haven Hospital as part of a partnership to improve chronic pain care in Ukraine. The program aims to modernize treatment standards and enhance capacity to address complex trauma and pain syndromes caused by wartime injuries.
• 4-CT (nonprofit)coreStrategic or Co-development PartnerNonprofit 4-CT provided a $75,000 grant to Yale New Haven Hospital researchers to study outcomes of a cash assistance program providing $500 one-time payments to violence victims. 4-CT is now expanding cash assistance programs to additional Connecticut cities including Waterbury and Bridgeport.
• Yale Cancer CentercoreStrategic or Co-development PartnerSmilow Cancer Hospital operates in affiliation with Yale Cancer Center, Connecticut's only National Cancer Institute-designated comprehensive cancer center. Patients have access to the most advanced clinical trials offered through Yale Cancer Center, home to world-leading cancer researchers.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Massachusetts General Hospital: Harvard-affiliated academic medical center and largest hospital in Massachusetts with comparable bed count, Magnet designation, NCI cancer center, and national specialty rankings — directly comparable as a flagship Northeast academic medical center.
• Brigham and Women's Hospital: Harvard Medical School teaching hospital with nationally ranked specialties in cancer, cardiology and neurology; structurally and operationally analogous to Yale New Haven as a specialty-dense academic referral center.
• NewYork-Presbyterian Hospital: Columbia/Cornell-affiliated academic medical center system with multiple specialty hospitals (cancer, children's, psychiatric) under one umbrella — the closest structural analog to Yale's multi-specialty flagship model.
• Hospital of the University of Pennsylvania (Penn Medicine): Ivy League-affiliated academic medical center with NCI cancer center, Magnet nursing, and national rankings across multiple specialties; competes with Yale for complex referrals from the mid-Atlantic and Northeast.
• Johns Hopkins Hospital: Top-ranked U.S. academic medical center with NIH-funded research, NCI cancer center, and similar teaching hospital structure; benchmark for clinical research output and specialty rankings.
• Mount Sinai Hospital: Icahn School of Medicine-affiliated academic medical center in New York with comparable scale, multi-specialty structure, and strong research and AI/digital health initiatives.
• Boston Children's Hospital: Harvard-affiliated pediatric specialty hospital and the leading U.S. children's hospital by U.S. News rankings; directly comparable to Yale New Haven Children's Hospital as a top-tier pediatric academic referral center.
• Dartmouth-Hitchcock Medical Center: New England academic medical center with similar bed scale, rural-referral model, and Geisel School of Medicine affiliation; comparable on academic medical center economics in the Northeast.

Regional players

• Hartford Hospital: Connecticut's other large tertiary hospital and Yale's principal in-state competitor for complex cases, particularly in cardiac and oncology; relevant regional comp for market share dynamics within Connecticut.

Emerging players

• Memorial Sloan Kettering Cancer Center: NCI-designated comprehensive cancer center that co-founded the Tempus AI digital pathology consortium with Yale; directly comparable on oncology specialty and a key consortium partner/peer for Smilow Cancer Hospital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ynhh
• Facebookfacebook.com/yalenewhavenhospital

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yale-New Haven Hospital